TRANSCRIPTIONAL REGULATION OF EMBRYONIC CARDIOGENESIS
TRANSCRIPTIONAL REGULATION OF EMBRYONIC CARDIOGENESIS
批准号:
7464617
负责人:
Robert Joel Schwartz
金额:
$45.19万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-06-01 至 2008-05-31
关键词:
ActinsAppearanceBindingBoxingCardiacCardiac MyocytesCell Differentiation processCellsCommitComplexDNA BindingDevelopmentDimerizationDockingEmbryoEnhancersFamily memberGene TargetingGenesGeneticGenomicsHeartHeart AtriumKnock-outLeftMaintenanceMapsMesodermMolecularMorphogenesisMusMuscle CellsMyocardialMyocardiumNatural regenerationNucleic Acid Regulatory SequencesPlayRegulationReplacement TherapyRoleSequence AlignmentSerum Response FactorSignal TransductionSmooth MuscleSpecific qualifier valueStem cellsSurfaceSystemTranscriptional RegulationTransgenic OrganismsUp-RegulationVentricularbasebeta Actincardiogenesiscell typecofactorcombinatorialcysteine rich proteinhomeodomainin vivomyogenesisprogenitorprogramstranscription factor
中文摘要
本项目和计划项目的一个统一主题是,心脏谱系的规范和心脏限制性基因的表达需要在心脏祖细胞出现期间发现的核心转录因子和这些基因调控区域的模块化组织之间的组合相互作用,以指导心脏和
英文摘要
A unifying theme of this project and the program project is that specification of cardiac lineages and expression of cardiac restricted genes requires combinatorial interactions between core transcription factors found to be enriched during the emergence of cardiac progenitor cells and the modular organization of regulatory regions of these genes to direct cardiac and
chamber specific gene activity. One of these core factors is Nkx2-5, a homeodomain gene, which is essential for normal heart morphogenesis, myogenesis and myocyte differentiation. Developmental regulation of the murine Nkx2-5 genetic locus is highly complex and modular. Currently, the left ventricular and atrium enhancers are still not identified. We propose to establish an efficient in vivo system for enhancer mapping of the mouse Nkx2-5 gene using Nkx2-5 BAC transgenics. Using a combination of strategies, that include nested transposon 10 deletions, identification of conserved genomic sequence alignments, transgenics and knockouts, we propose to detect and characterize potential chamber specific enhancer/repressor regions of Nkx2-5. Another core factor, serum response factor (SRF) may play a leading role in the commitment of cardiac progenitors by virtue of its obligatory requirement for cardiac mesoderm formation and by its ability for interacting in a combinatorial manner with other early cardiac enriched transcription factors. SRF assists as a docking surface for the binding of cofactors, such as Nkx2-5 and GATA-4 that may confer the regulation of specific gene programs. We have found that restricted expression of SRF closely overlapped with such as Nkx2-5, GATA4 and CRPI/2 (smooth muscle Lim only factors), in early vertebrate embryos, coincident with the earliest appearance of smooth muscle target genes and nascent myocardial cells. This transcription factor complex,was central for the de novo upregulation of smooth muscle specified genes. We discovered that the appearance of dHAND in combination with Nkx2-5, SRF, GATA4, and CRPt/2 activated striated beta-actin gene activity. We propose to investigate the molecular basis underlying the specification, and maintenance of cardiac muscle cell differentiation, and the modular regulation of Nkx2-5 to understand early development of multichambered heart and provide opportunities for cell replacement therapy and heart regeneration. The following aims are: To determine how modular genetic regions provide for cardiogenic regulatory activity of the Nkx2-5 gene locus? To determine how SRF specifies procardiac mesoderm to committed cardiogenic cell types? To determine how CRP Lim only family members direct early procardiogenic gene activity and how the appearance of dHAND
and CRP3 switches on cardiogenic gene activity in committed cardiomyoctyes?
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Role of Cysteine Rich Protein2 Binding Protein in Cardiovascular Development
-
批准号:7787059
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2009
-
负责人:Robert Joel Schwartz
-
依托单位:
The Role of Cysteine Rich Protein2 Binding Protein in Cardiovascular Development
-
批准号:8053758
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2009
-
负责人:Robert Joel Schwartz
-
依托单位:
The Role of Cysteine Rich Protein2 Binding Protein in Cardiovascular Development
-
批准号:7583897
-
项目类别:
-
资助金额:$36.63万
-
财政年份:2009
-
负责人:Robert Joel Schwartz
-
依托单位:
The Role of Cysteine Rich Protein2 Binding Protein in Cardiovascular Development
-
批准号:8248718
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2009
-
负责人:Robert Joel Schwartz
-
依托单位:
TRANSCRIPTIONAL REGULATION OF EMBRYONIC CARDIOGENESIS
-
批准号:7255605
-
项目类别:
-
资助金额:$34.74万
-
财政年份:2006
-
负责人:Robert Joel Schwartz
-
依托单位:
Cardiogenic Gene Switch, Role of SRF Phosphorylation
-
批准号:7008156
-
项目类别:
-
资助金额:$35.52万
-
财政年份:2005
-
负责人:Robert Joel Schwartz
-
依托单位:
Cardiogenic Gene Switch, Role of SRF Phosphorylation
-
批准号:7335618
-
项目类别:
-
资助金额:$34.49万
-
财政年份:2005
-
负责人:Robert Joel Schwartz
-
依托单位:
Cardiogenic Gene Switch, Role of SRF Phosphorylation
-
批准号:7161715
-
项目类别:
-
资助金额:$34.49万
-
财政年份:2005
-
负责人:Robert Joel Schwartz
-
依托单位:
Cardiogenic Gene Switch, Role of SRF Phosphorylation
-
批准号:6873815
-
项目类别:
-
资助金额:$36.38万
-
财政年份:2005
-
负责人:Robert Joel Schwartz
-
依托单位:
RhoA signaling pathway in stretch mediated cardiac hypertrophy
-
批准号:6569681
-
项目类别:
-
资助金额:$18.5万
-
财政年份:2002
-
负责人:Robert Joel Schwartz
-
依托单位:
RhoA signaling pathway in stretch mediated cardiac hypertrophy
-
批准号:6564975
-
项目类别:
-
资助金额:$18.5万
-
财政年份:2002
-
负责人:Robert Joel Schwartz
-
依托单位:
TRANSCRIPTIONAL REGULATION OF EMBRYONIC CARDIOGENESIS
-
批准号:6594617
-
项目类别:
-
资助金额:$17.52万
-
财政年份:2002
-
负责人:Robert Joel Schwartz
-
依托单位:
TRANSCRIPTIONAL REGULATION OF EMBRYONIC CARDIOGENESIS
-
批准号:6593869
-
项目类别:
-
资助金额:$17.52万
-
财政年份:2002
-
负责人:Robert Joel Schwartz
-
依托单位:
TRANSCRIPTIONAL REGULATION OF EMBRYONIC CARDIOGENESIS
-
批准号:6449406
-
项目类别:
-
资助金额:$17.52万
-
财政年份:2001
-
负责人:Robert Joel Schwartz
-
依托单位:
RhoA signaling pathway in stretch mediated cardiac hypertrophy
-
批准号:6423881
-
项目类别:
-
资助金额:$18.5万
-
财政年份:2001
-
负责人:Robert Joel Schwartz
-
依托单位:
TRANSCRIPTIONAL REGULATION OF EMBRYONIC CARDIOGENESIS
-
批准号:6311650
-
项目类别:
-
资助金额:$17.35万
-
财政年份:2000
-
负责人:Robert Joel Schwartz
-
依托单位:
RHOA KINASES IN CARDIAC HYPERTROPHY
-
批准号:6499059
-
项目类别:
-
资助金额:$70.12万
-
财政年份:2000
-
负责人:Robert Joel Schwartz
-
依托单位:
RHOA KINASES IN CARDIAC HYPERTROPHY
-
批准号:6052785
-
项目类别:
-
资助金额:$38.88万
-
财政年份:2000
-
负责人:Robert Joel Schwartz
-
依托单位:
RHOA KINASES IN CARDIAC HYPERTROPHY
-
批准号:6351620
-
项目类别:
-
资助金额:$40.21万
-
财政年份:2000
-
负责人:Robert Joel Schwartz
-
依托单位:
RhoA signaling pathway in stretch mediated cardiac hypertrophy
-
批准号:6302325
-
项目类别:
-
资助金额:$18.5万
-
财政年份:2000
-
负责人:Robert Joel Schwartz
-
依托单位:
海外基金